Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹1240 Cr.
Stock P/E
37.3
P/B
1.6
Current Price
₹442.4
Book Value
₹ 278.6
Face Value
10
52W High
₹507.9
52W Low
₹ 195.2
Dividend Yield
0%

Valiant Organics Overview

Business

Valiant Organics Ltd. is an Indian chemical manufacturing company primarily engaged in the production of specialty chemicals, intermediates, and bulk chemicals. Its product range often caters to various industries, including pharmaceuticals, agrochemicals, dyes, pigments, polymers, and other industrial applications. The company operates on a business-to-business (B2B) model, generating revenue by manufacturing and selling these chemical products to its industrial clients.

Revenue Mix

Without specific published data, it is not possible to provide an exact revenue mix. However, typical chemical companies like Valiant Organics often have product segments based on their chemical processes or end-user applications. These could include:

Pharma Intermediates

Agrochemical Intermediates

Specialty Chlorination Products

Dyes & Pigments Intermediates

Detailed segmentation would typically be found in the company's annual reports or investor presentations.

Industry

The Indian chemicals industry is a diverse and growing sector, driven by strong domestic consumption, government initiatives for 'Make in India,' and the global 'China+1' strategy leading to supply chain diversification. The industry is competitive, comprising large diversified players, mid-sized specialty chemical manufacturers, and smaller regional entities. Valiant Organics likely positions itself as a focused manufacturer of specific chemistries and intermediates, aiming to provide critical raw materials or building blocks to larger downstream industries. Its standing relative to peers would depend on its specific product portfolio, cost efficiency, and market share in its niche areas.

MOAT

Valiant Organics' potential competitive advantages could include:

Process Expertise: Specialized know-how in complex chemical reactions and processes, leading to efficient and cost-effective manufacturing.

Customer Relationships: Established, long-term relationships with key industrial customers, potentially leading to high switching costs due to product customization and reliability.

Product Portfolio: A diversified yet specialized product basket that serves critical needs across multiple end-user industries.

Regulatory Compliance: Adherence to stringent quality and environmental standards, which can be a barrier for new entrants.

Growth Drivers

Rising Demand from End-User Industries: Continued growth in sectors like pharmaceuticals, agrochemicals, and other manufacturing industries in India drives demand for intermediates and specialty chemicals.

Import Substitution: Government focus and industry efforts to reduce reliance on imported chemicals, especially from China, create opportunities for domestic manufacturers.

Capacity Expansion & Diversification: The company investing in new projects or expanding existing capacities to cater to growing demand and enter new product lines.

'China+1' Strategy: Global companies diversifying their supply chains away from China, viewing India as an attractive alternative manufacturing hub.

R&D and Product Innovation: Development of new, value-added products and exploring advanced chemistries to capture new markets.

Risks

Raw Material Price Volatility: Fluctuations in prices of key feedstocks, often linked to crude oil or other global commodities, can impact profit margins.

Environmental & Regulatory Changes: Increasing stringency of environmental norms and safety regulations can lead to higher compliance costs or operational disruptions.

Intense Competition: The fragmented nature of the Indian chemical industry can lead to pricing pressures and margin erosion.

Demand Cyclicality: Demand for certain chemicals can be tied to broader economic cycles or specific industry trends, leading to volatility in revenue.

Foreign Exchange Fluctuations: As an exporter and/or importer of raw materials, currency volatility can impact profitability.

Management & Ownership

Valiant Organics Ltd. is typically a promoter-led company, a common structure in India. This often implies strong operational control and long-term vision from the founding family or group. The management's quality would be reflected in their strategic foresight, operational efficiency, track record of growth, and adherence to corporate governance standards. The ownership structure generally involves the promoter group holding a significant stake, complemented by institutional investors and public shareholders.

Outlook

Valiant Organics operates within a dynamic and expanding Indian chemical sector, benefiting from both domestic industrial growth and global supply chain realignments. The company's specialization in intermediates and specialty chemicals offers opportunities for value creation and niche market leadership. However, the business faces inherent risks such as raw material price fluctuations, intense competition, and evolving environmental regulations. Its ability to capitalize on growth opportunities will depend on successful execution of capacity expansions, continuous product innovation, maintaining cost efficiencies, and adeptly navigating the competitive and regulatory landscape while leveraging the broader tailwinds for India's manufacturing sector.

Valiant Organics Share Price

Live · BSE / NSE · Inception: 2005
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Valiant Organics Quarterly Results

#(Fig in Cr.) Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 177 168 160 187 204 204 157 159 218 232
Other Income 2 0 3 5 1 1 0 2 4 3
Total Income 179 168 163 192 204 205 158 161 222 235
Total Expenditure 179 152 158 172 183 180 136 144 191 190
Operating Profit 0 16 5 20 21 26 21 17 30 45
Interest 7 5 8 6 5 6 4 5 3 5
Depreciation 9 9 9 9 9 9 10 10 10 10
Exceptional Income / Expenses -9 0 0 0 0 0 0 6 0 0
Profit Before Tax -25 2 -12 6 7 10 7 8 17 30
Provision for Tax -5 3 -1 1 3 3 2 2 2 8
Profit After Tax -20 -0 -11 5 4 8 6 6 15 22
Adjustments -0 -0 -2 1 0 1 0 -2 1 7
Profit After Adjustments -20 -1 -13 5 4 8 6 4 16 29
Adjusted Earnings Per Share -7.3 -0.2 -4.6 2 1.5 2.9 2 1.3 5.6 10.4

Valiant Organics Profit & Loss

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Net Sales 692 675 755 1153 1052 723 719 739 766
Other Income 9 6 6 7 8 10 9 7 9
Total Income 701 681 761 1161 1060 733 728 746 776
Total Expenditure 512 494 550 948 888 685 665 651 661
Operating Profit 189 187 211 212 172 48 63 95 113
Interest 4 3 5 6 11 16 24 18 17
Depreciation 14 16 21 30 29 35 36 40 40
Exceptional Income / Expenses 0 0 0 0 5 -3 0 6 6
Profit Before Tax 171 168 185 176 137 -9 2 42 62
Provision for Tax 50 42 54 48 35 -0 6 9 14
Profit After Tax 121 126 131 128 103 -8 -3 33 49
Adjustments 12 -2 -16 -15 -14 0 -0 0 6
Profit After Adjustments 133 124 115 113 88 -8 -4 33 55
Adjusted Earnings Per Share 113.6 51 42.2 41.7 32.5 -3 -1.3 11.9 19.3

Valiant Organics Balance Sheet

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Shareholder's Funds 259 388 503 613 689 729 725 759
Minority's Interest 12 13 6 36 51 0 0 -0
Borrowings 44 84 75 106 71 74 51 53
Other Non-Current Liabilities 15 15 22 28 36 33 38 69
Total Current Liabilities 117 169 270 409 393 412 369 350
Total Liabilities 448 669 876 1192 1239 1248 1183 1231
Fixed Assets 150 276 510 543 670 643 657 695
Other Non-Current Assets 80 169 63 122 98 192 170 184
Total Current Assets 218 224 303 527 471 413 356 352
Total Assets 448 669 876 1192 1239 1248 1183 1231

Valiant Organics Cash Flow

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Opening Cash & Cash Equivalents 13 3 8 13 25 8 3 7
Cash Flow from Operating Activities 76 161 115 -31 238 84 56 92
Cash Flow from Investing Activities -88 -184 -159 -124 -143 -65 -21 -86
Cash Flow from Financing Activities 1 27 49 167 -112 -23 -32 -11
Net Cash Inflow / Outflow -11 5 5 12 -17 -4 4 -5
Closing Cash & Cash Equivalent 4 8 13 25 8 3 7 2

Valiant Organics Ratios

# Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Earnings Per Share (Rs) 113.6 51 42.19 41.72 32.45 -3.04 -1.33 11.86
CEPS(Rs) 115.01 58.43 56.02 58.02 48.52 9.62 11.55 25.98
DPS(Rs) 12 11 5 3.5 1 0 0 0
Book NAV/Share(Rs) 213.89 158.75 184.83 225.66 253.42 264.18 258.91 270.84
Core EBITDA Margin(%) 26.03 26.75 27.18 17.76 15.61 5.23 7.51 11.94
EBIT Margin(%) 25.32 25.34 25.15 15.84 14.07 1.06 3.65 8.14
Pre Tax Margin(%) 24.73 24.96 24.49 15.28 13.04 -1.2 0.3 5.68
PAT Margin (%) 17.51 18.7 17.34 11.09 9.75 -1.16 -0.48 4.5
Cash Profit Margin (%) 19.48 21.03 20.15 13.66 12.53 3.67 4.5 9.85
ROA(%) 27.05 22.59 16.94 12.37 8.44 -0.68 -0.28 2.75
ROE(%) 48.33 39.65 29.49 22.95 15.77 -1.19 -0.47 4.48
ROCE(%) 51.25 39.4 30.68 21.66 15.28 0.79 2.67 6.05
Receivable days 74.54 74.08 69.97 75.6 99.81 117.03 98.07 103.8
Inventory Days 25.26 25.09 28.3 29.4 41.62 60.69 51.6 44.59
Payable days 68.9 75.28 88.54 57.09 79.87 143.02 142.17 112.98
PER(x) 6.64 10.24 30.64 22.05 12.85 0 0 17.07
Price/Book(x) 3.53 3.29 7 4.08 1.65 1.44 1.01 0.75
Dividend Yield(%) 0.8 1.05 0.39 0.38 0.24 0 0 0
EV/Net Sales(x) 1.39 2.07 4.89 2.44 1.33 1.8 1.35 1.11
EV/Core EBITDA(x) 5.1 7.48 17.48 13.27 8.11 27.34 15.46 8.61
Net Sales Growth(%) 0 -2.51 11.83 52.79 -8.8 -31.26 -0.59 2.78
EBIT Growth(%) 0 -2.41 10.99 -3.8 -18.99 -94.83 242.55 129.47
PAT Growth(%) 0 4.08 3.7 -2.26 -19.82 -108.19 59.18 1069.44
EPS Growth(%) 0 -55.1 -17.28 -1.12 -22.21 -109.38 56.16 989.11
Debt/Equity(x) 0.33 0.36 0.41 0.59 0.4 0.35 0.34 0.33
Current Ratio(x) 1.86 1.33 1.12 1.29 1.2 1 0.97 1.01
Quick Ratio(x) 1.45 1.06 0.86 1.01 0.88 0.73 0.72 0.74
Interest Cover(x) 43.19 66.57 37.99 28.19 13.71 0.47 1.09 3.3
Total Debt/Mcap(x) 0.09 0.11 0.06 0.15 0.24 0.24 0.34 0.45

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +3% -11% 0% —
Operating Profit CAGR +51% -18% -15% —
PAT CAGR — -32% -24% —
Share Price CAGR +45% 0% -21% +8%
ROE Average +4% +1% +8% +20%
ROCE Average +6% +3% +9% +21%

Valiant Organics Shareholding Pattern

Latest · Sep 2026
100% held
Promoters 37.89 %
FII 0.43 %
DII (MF + Insurance) 0.03 %
Public (retail) 61.64 %
Others 0.01 %
# Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Promoter 37.7737.7737.7437.9137.9137.9137.8937.8937.8737.89
FII 1.351.330.820.370.210.210.230.280.210.43
DII 0.090.0800000000.03
Public 60.7960.8261.4461.7161.8761.8861.8861.8261.9261.64
Others 0000000000
Total 100100100100100100100100100100

Valiant Organics Peer Comparison

Chemicals Edit Columns

Valiant Organics Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Valiant Organics Pros & Cons

Pros

  • Debtor days have improved from 142.17 to 112.98days.
  • Company is almost debt free.

Cons

  • Promoter holding is low: 37.89%.
  • Company has a low return on equity of 1% over the last 3 years.
  • The company has delivered a poor profit growth of -24% over past five years.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp